Evolus, Inc.

NASDAQ:EOLS

16.69 (USD) • At close October 29, 2024
Bedrijfsnaam Evolus, Inc.
Symbool EOLS
Munteenheid USD
Prijs 16.69
Beurswaarde 1,053,047,205
Dividendpercentage 0%
52-weken bereik 7.44 - 17.82
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. David Moatazedi
Website https://www.evolus.com

An error occurred while fetching data.

Over Evolus, Inc.

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was

Vergelijkbare Aandelen

Rocket Pharmaceuticals, Inc. logo

Rocket Pharmaceuticals, Inc.

RCKT

17.35 USD

The Oncology Institute, Inc. logo

The Oncology Institute, Inc.

TOI

0.32 USD

Codexis, Inc. logo

Codexis, Inc.

CDXS

3.19 USD

Nektar Therapeutics logo

Nektar Therapeutics

NKTR

1.27 USD

SIGA Technologies, Inc. logo

SIGA Technologies, Inc.

SIGA

7.11 USD

Merus N.V. logo

Merus N.V.

MRUS

51.92 USD

uniQure N.V. logo

uniQure N.V.

QURE

6.42 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)